BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Hepatitis D Reports From BioPortfolio:

Market Research Reports / Management Reports / Research Reports

BioPortfolio Limited Global Hepatitis Strategies
Etiology, Prophylaxis, and Therapy for Hepatitis A, B, C, D and E. Theoretical Revenues for Diagnosis, Screening and Therapeutics representing the potential
...
http://www.bioportfolio.com/cgi-bin/acatalog/Global_Hepatiti...

BioPortfolio Limited Molecular Diagnostics Markets
3.2.2.4 Hepatitis D Virus (HDV) 62 3.2.2.5 Hepatitis E Virus (HEV) 62 3.2.2.6 HBV/HCV Viral Load and Drug Resistance 62 3.2.3 Severe Acute Respiratory ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_108.html...

BioPortfolio Limited Global Hepatitis Strategies
Hepatitis C. The Virus; Etiology; Pathology. Hepatitis D ... Hepatitis C. Geographic Patterns. Hepatitis D. Geographic Patterns. Hepatitis E ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_799.html...

BioPortfolio Limited High-Growth Diagnostic Testing Markets
Table 4.9: Recommendations for Diagnostic Testing for Hepatitis C 60 ... Table 5.17: Clinical Characteristics of D-dimer 83 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1179.html...

Buisness Insights Pharmaceutical and Biotechnology Reports
The adult segment discusses indications such as hepatitis, influenza, ...... Translational Medicine in Biopharmaceutical R and D - Enabling R and D ...
http://www.bioportfolio.com/cgi-bin/acatalog/Business_Insigh...

Datamonitor Healthcare, Biotechnology and Pharmaceutical ...
Understand current and future Hepatitis C market dynamics ..... D-Pharm's DP-VPA (a prodrug of valproic acid), has not made any known progress through ...
http://www.bioportfolio.com/cgi-bin/acatalog/BioPortfolio_Da...

BIOPHARMA: Biopharmaceutical Products in the U.S. Market The only ...
Hib & Hepatitis B Vaccine, rDNA 325. Hepatitis A Vaccine Products 327 .... Rho(D ) Immune Globulin Products 585. Rho(D) Immune Globulin/Bayer 586 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_76.html...

BioPortfolio Limited Vaccines 2009: World Market Analysis, Key ...
Allergy; BCG; Cancer; Cervical Cancer; Cholera; Diphtheria-Tetanus; Helicobacter Pylori; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1383.html...

BioPortfolio Limited
Molecular Imaging in Drug R and D and Medical Practice Technologies, ..... Pipeline and Commercial Insight: Hepatitis C - High unmet need drives rapid ...
http://www.bioportfolio.com/cgi-bin/acatalog/sitemap.html...

TABLE OF CONTENTS
for HIV, Hepatitis B, Hepatitis C, polio virus, severe acute respiratory syndrome virus (SARS), .... Dale Pfost, Ph.D., Chairman, President and CEO ...
http://www.bioportfolio.com/cgi-bin/acatalog/9164_RNAI.pdf...

Results from other life science and pharmaceutical sites:

Director's Report 5/00 - Publications
The Research Report Series provides an authoritative and unbiased overview ... posed by hepatitis C infection and its association with injection drug use. ....
Hogan, D., Etz, K., and Tudge, J. Reconsidering The Role of Children in Family
... G. Preparing Graduate Students For A Diverse Job Market: A Comparison Of ...
http://www.nida.nih.gov/DirReports/DirRep500/DirectorReport1...

Gilead Sciences Annual Report 2002
building visibility in the hepatitis B market. Gilead's revenues in 2002, primarily driven ..... proprietary market research, 2001). Fewer than 30 percent
of patients with .... achievements were recognized with the James D. Watson
Helix ...
http://www.gilead.com/pdf/gilead_ar2002.pdf...

NIDA - Director's Report - May, 2006
23 Jul 2008 ... The Prevention Research Branch of the Division of Epidemiology, Services, ... Dr . Diana received his Ph.D. in sociology from Northeastern University ... DPMCDA,
who was responsible for research program on hepatitis C infection ... business
development and marketing in the Olympus Corporation and in ...
http://www.nida.nih.gov/DirReports/DirRep506/DirectorReport2...

OTT Rare Diseases List
Technologies Available for Licensing from NIH/FDA Hepatitis D .... The diagnostic market is a multi-billion dollar market, with a need for more .... a
way that may facilitate advanced research in the field of hepatitis C (HCV) and
.... of hepatitis reported in the United States, which reports an estimated
134000 ...
http://ott.od.nih.gov/Technologies/RareDiseases.aspx?RareDis...

NLM Classification Index H
6 Apr 2009 ... Health Services Marketing see Marketing of Health Services; Mesh Browser ... Health Services Research W 84.3: In special areas, by subject; Health Services,
..... Hepatitis D WC 536; Hepatitis D Virus see Hepatitis Delta Virus .....
Administrative serial reports (all types of hospitals) WX 2 ...
http://www.nlm.nih.gov/class/index_h.html...

1 NIDA Heroin RRS
2NIDA RESEARCH REPORT SERIES heroin in the past year, and the group that represented the high- .... infections with hepatitis B and C,. HIV, and a host
of other blood- borne viruses, which drug .... bring buprenorphine to market in
the U.S., 1994. .... Lewis, J.W.; and Walter, D. Buprenorphine: Background to
its ...
http://www.nida.nih.gov/PDF/RRHeroin.Pdf...

Hepatitis B virus, the vaccine, and the control of primary cancer ...
However, building on a large body of research on hepatitis over the preceding ... mostly unrelated, viruses [hepatitis viruses A, B, C, D, E, and G (HAV, HBV,
..... kits of increasing sensitivity to tap the enormous market for the testing
the .... Several reports were presented at the IX Triennial International ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC33676/...

NIDA - Director's Report - May, 2009
10 Jul 2009 ... Research Findings - Research on Medical Consequences of Drug Abuse and .... Hepatitis C virus (HCV) infection can promote the development of hepatocellular
carcinoma (HCC). ... Continued flux in the heroin market and its effects on the
risk ... Ciccarone D. International Journal of Drug Policy. ...
http://www.nida.nih.gov/DirReports/DirRep509/DirectorReport9...

Abbott Reports Double-Digit Sales and Earnings Growth in Fourth ...
d, Without the negative impact of exchange of 6.2 percent, Sevorane sales ..... XIENCE V – In June 2008, Abbott submitted a marketing authorization license
application in ... Abbott is conducting innovative research in neuroscience, ...
Abbott has several active hepatitis C programs including our partnership with
...
http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/P...

Report of the Chimpanzee Management Plan Working Group - Friday ...
22 May 2007 ... Chimpanzees in Hepatitis Research: Dr. T. Jake Liang, Chief, Liver Diseases Branch ... for market evaluation and to determine how many centers are needed.
... Stuart Zola, Ph.D., Yerkes National Primate Research Center). ...
http://www.ncrr.nih.gov/comparative_medicine/chimpanzee_mana...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.